The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
about
Chronic neutrophilic leukemia: a clinical perspectiveChk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibitionRas/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions.Biased random walk model for the prioritization of drug resistance associated proteins."Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo.Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells.Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions.Pim-3 is a Critical Risk Factor in Development and Prognosis of Prostate Cancer.CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia.Insights from Pim1 structure for anti-cancer drug design.Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.Genetically engineered mouse models of human B-cell precursor leukemias.Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks.Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia.Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach.PIM Kinase as an Executional Target in Cancer
P2860
Q26781167-6682555E-E31A-4562-87EF-10CD87D8B28DQ28396027-E680785B-1386-4FA0-913B-D8417164F45BQ34307356-D9148442-8D6F-4EA8-8392-B4223101E87AQ34654508-1B221D32-9348-4A35-B4D0-CC7ED95E9E80Q35679339-A39CC8A7-CE68-4E00-81D9-51EF62D5695AQ35799776-3DCC791F-9E3C-442A-8043-685533E28716Q36342079-9CC1D261-F847-404B-AC6C-7BF6892C28E4Q36926148-2EC078FD-799B-4146-A987-5A2FA60AB03EQ37412622-31BE88BA-4066-4979-9C69-6EA4BD0377A8Q37431993-221A8B49-279A-41C2-A655-3D67B7111539Q38045948-C4341C73-A8AA-4587-A9FC-10094DDB0A84Q38260135-E1217CBE-9E1C-4255-A0B4-91BFE43F308EQ38285177-8611DB17-2F61-4F87-9235-065A9CA099F1Q38960311-39FB9223-639E-46D3-B3BC-3623F0F0A11CQ39283981-A30E3697-50CD-400F-8C78-4DFF34F10345Q41733002-902595F7-ED68-42B4-A642-5CDD380234B1Q52571251-60D46A1C-E072-49E8-A704-45173802BD70Q54380317-57ACA2CB-82A1-4FC1-B9DD-1F3A1F311D82Q58128483-019C5C78-993C-4EAE-BFA7-9C41314D54AF
P2860
The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The direct Myc target Pim3 coo ...... Myc-induced B-cell lymphomas.
@en
The direct Myc target Pim3 coo ...... Myc-induced B-cell lymphomas.
@nl
type
label
The direct Myc target Pim3 coo ...... Myc-induced B-cell lymphomas.
@en
The direct Myc target Pim3 coo ...... Myc-induced B-cell lymphomas.
@nl
prefLabel
The direct Myc target Pim3 coo ...... Myc-induced B-cell lymphomas.
@en
The direct Myc target Pim3 coo ...... Myc-induced B-cell lymphomas.
@nl
P2093
P2860
P356
P1433
P1476
The direct Myc target Pim3 coo ...... Myc-induced B-cell lymphomas.
@en
P2093
Jonas Nilsson
Linus Plym Forshell
Lisa Nilsson
Martina Rudelius
Tacha Zi Plym Forshell
Ulrich Keller
Yongmei Li
P2860
P304
P356
10.18632/ONCOTARGET.283
P407
P577
2011-06-01T00:00:00Z